SBILIFE

SBI Life Insurance outperformed the Sensex by gaining 2.19% against the benchmark’s 0.60%. However, over the past month, the stock’s 1.22% gain lagged behind the Sensex’s 5.20% rise. Year-to-date, both the stock and the Sensex have declined by nearly identical margins, around 8.5%. Over a longer horizon, the stock has delivered robust returns, with a 7.96% gain over one year compared to the Sensex’s 3.33% loss, and an impressive 58.60% over three years versus the Sensex’s 27.69%. The five-year return of 92.01% also significantly outpaces the benchmark’s 59.26%. From a valuation standpoint, SBI Life Insurance is trading at a price-to-book value of 9.9, which is considered a premium relative to its peers’ historical averages. The company’s return on equity (ROE) stands at 13%, indicating a fair valuation given its profitability. However, the price-to-earnings-growth (PEG) ratio is notably high at 33.4, reflecting that the stock’s price growth may be outpacing its earnings growth, which has risen modestly by 2.4% over the past year.